The FDA has approved a new drug called Trelstar (triptorelin pamoate) for the treatment of advanced prostate cancer. This medicine works by lowering the amount of testosterone in the body, which can help slow the growth of cancer cells. It is given as a shot into a muscle, and there are three different dosing schedules: every 4 weeks, every 12 weeks, or every 24 weeks. Your doctor will choose the schedule that is right for you.
Trelstar is for people with advanced prostate cancer, meaning the cancer has spread or is at high risk of spreading. It is a type of hormone therapy, also called androgen deprivation therapy. This approval gives doctors and patients more choices when deciding on treatment.
The approval means that Trelstar is now available as a treatment option. However, it is not a cure for prostate cancer. Like all medicines, it can have side effects. Common side effects may include hot flashes, decreased libido, and injection site reactions.
If you or a loved one has advanced prostate cancer, talk to your doctor about whether Trelstar might be a good option. Your doctor can help you understand the benefits and risks based on your specific health situation.
